deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT03036605

The Effect of Dexamethasone Added to Bupivacain in Nasal Surgery

The Postoperative Analgesic Effect of Dexamethasone Added to Topical Bupivacaine in Endoscopic Nasal Surgery

Sponsor: Ataturk University

Conditions Nasal Surgery
Updated 8 times since 2017 Last updated: Jun 6, 2017 Started: Mar 15, 2017 Primary completion: Apr 1, 2017 Completion: May 15, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03036605, this PHASE4 trial focuses on Nasal Surgery and remains completed. Sponsored by Ataturk University, it has been updated 8 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Feb 2017 – ~Mar 2017 · 28 days · monthly snapshotNot Yet Recruiting~Mar 2017 – ~Jun 2017 · 3 months · monthly snapshotRecruiting~Jun 2017 – ~Jun 2018 · 12 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 12 months · monthly snapshotCompleted

Change History

8 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

Show 3 earlier versions
  1. Jun 2017 — Jun 2018 [monthly]

    Completed PHASE4

    Status: RecruitingCompleted

  2. Mar 2017 — Jun 2017 [monthly]

    Recruiting PHASE4

    Status: Not Yet RecruitingRecruiting

  3. Feb 2017 — Mar 2017 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ataturk University
Data source: Ataturk University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations